Product
asenapine
Name
Asenapine
INN Name
asenapine maleate
FDA Approved
Yes
2 clinical trials
7 organizations
6 indications
2 documents
Indication
SchizophreniaIndication
Delusional disorderIndication
DisorganizedIndication
UndifferentiatedIndication
Bipolar DisorderIndication
PediatricClinical trial
A 26-week, Multi-center, Open-label, Flexible Dose, Long-term Safety Trial of Asenapine in Adolescent Subjects With SchizophreniaStatus: Completed, Estimated PCD: 2013-10-07
Clinical trial
Efficacy and Safety of 3-Week Fixed-Dose Asenapine Treatment in Pediatric Acute Manic or Mixed Episodes Associated With Bipolar I Disorder (Protocol No. P06107)Status: Completed, Estimated PCD: 2013-08-28
Organization
MSN LABORATORIES PRIVATE LIMITEDOrganization
Alembic Pharmaceuticals Inc.Organization
Sigmapharm Laboratories, LLCDocument
DailyMed Label: SECUADOOrganization
Noven Therapeutics, LLCOrganization
Greenstone LLCDocument
DailyMed Label: AsenapineOrganization
Alembic Pharmaceuticals LimitedOrganization
Breckenridge Pharmaceutical, Inc.